Novel Immunotherapy Promising Against High-Risk Prostate Cancers

被引：0
|
作者：
不详
机构：
来源：
US PHARMACIST | 2023年 / 48卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：31 / 33
页数：3
相关论文
共 50 条
  • [31] Choosing the ideal immunotherapy for high-risk ALL
    Peters, Christina
    LANCET HAEMATOLOGY, 2022, 9 (08): : E560 - E561
  • [32] Immunotherapy in the Adjuvant Setting for High-Risk Melanoma
    Weber, Jeffrey S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (08) : 546 - 548
  • [33] Surgery for high-risk prostate cancer
    Eden, Christopher
    TRENDS IN UROLOGY & MENS HEALTH, 2014, 5 (01) : 19 - 22
  • [34] High-risk prostate cancer: How high is high?
    Sandler, HM
    CANCER JOURNAL, 2002, 8 (04): : 301 - 302
  • [35] POLYSIALIC ACID AS A NOVEL CARBOHYDRATE BIOMARKER FOR INTERMEDIATE AND HIGH-RISK PROSTATE CANCER
    Williams, Karla
    Willis, Lisa
    Fazli, Ladan
    Fleshner, Neil
    Nitz, Mark
    Cox, Michael
    Leong, Hon
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1150 - E1150
  • [36] Novel immunotherapy off ers promising weapon against canine melanoma
    Fan, Timothy M.
    Garrett, Laura D.
    Selting, Kim A.
    Constable, Peter D.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2022, 83 (10)
  • [37] Genomics and risk stratification in high-risk prostate cancer
    Al Awamlh, Bashir Al Hussein
    Shoag, Jonathan E.
    NATURE REVIEWS UROLOGY, 2019, 16 (11) : 641 - 642
  • [38] Genomics and risk stratification in high-risk prostate cancer
    Bashir Al Hussein Al Awamlh
    Jonathan E. Shoag
    Nature Reviews Urology, 2019, 16 : 641 - 642
  • [39] CLINICAL GRADE ACTIVATED NATURAL KILLER PRODUCTS FOR ADOPTIVE IMMUNOTHERAPY AGAINST HIGH-RISK MALIGNANCIES
    Perez Martinez, A.
    Corral-Sanchez, D.
    Fernandez, L.
    Leivas, A.
    Valentin, J.
    de Paz, R.
    Rodriguez, R.
    Campana, D.
    Martinez, J.
    HAEMATOLOGICA, 2015, 100 : 289 - 290
  • [40] MINNELIDE, A PROMISING COMPOUND FOR THE TREATMENT OF HIGH-RISK MEDULLOBLASTOMA
    Blanco, Jezabel Rodriguez
    Salvador, April
    Sahani, Pritika
    Kliebe, Valentin
    Peterson, Kendell
    Turos, Maria
    NEURO-ONCOLOGY, 2024, 26
12345